Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Biobusiness Briefs
  • Published:

Regulatory watch

Impact of scientific advice from the European Medicines Agency

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Impact of scientific advice.

Acknowledgements

The views expressed in this article are the personal views of the authors and may not be understood or quoted as being made on behalf of or reflecting the position of the European Medicines Agency or one of its committees or working parties.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jan Regnstrom.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Supplementary information

Supplementary information S1 (box)

Definitions and data analysis (PDF 140 kb)

Supplementary information S2 (table)

Summary of MAA submissions, SA requests and compliance with SA by year (PDF 107 kb)

Supplementary information S3 (table)

MAA procedure time and the number of MOs in relation to compliance with SA on clinical trial design (PDF 97 kb)

PowerPoint slides

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hofer, M., Jakobsson, C., Zafiropoulos, N. et al. Impact of scientific advice from the European Medicines Agency. Nat Rev Drug Discov 14, 302–303 (2015). https://doi.org/10.1038/nrd4621

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrd4621

This article is cited by

Search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research